It has been reported that CYP7B1 (the enzyme responsible for catabolizing 27HC) expression and not CYP27A1 correlates better with 27HC levels in thyroid cancer28 and CYP7B1 has been shown to influence immune function in tumor progression and associated to BC prognosis10,13. This evidence concerns the gene CYP27A1 and breast cancer.